Systemic and neurologic autoimmune disorders associated with seizures or epilepsy

被引:62
|
作者
Vincent, Angela [1 ]
Crino, Peter B. [2 ,3 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
[2] Univ Penn, Med Ctr, PENN Epilepsy Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
关键词
Multiple sclerosis; Systemic lupus erythematosus; Celiac disease; Cerebral calcification; Diabetes; Hashimoto's; MULTIPLE-SCLEROSIS; HASHIMOTO ENCEPHALOPATHY; AUTOANTIBODIES; PROGNOSIS;
D O I
10.1111/j.1528-1167.2011.03030.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P>In this article, we review the incidence and significance of seizures in well-established autoimmune disorders, including multiple sclerosis (MS), diabetes mellitus, celiac disease, thyroid disease, and systemic lupus erythematosus (SLE). The five following presentations discuss the incidence and possible pathogenesis of epilepsies that are found in these well-known autoimmune conditions. There is a large body of evidence describing the clinical presentation of seizures with MS and SLE, and showing that refractory epilepsy can complicate these already challenging disorders. However, the mechanisms involved are complex and generally not well understood. Neurologic syndromes, including seizure disorders, can also be a feature of celiac disease (CD) or subclinical CD, sometimes associated with cerebral calcification. The association between type-1 diabetes mellitus (T1DM) and epilepsy is unclear and requires more definitive epidemiologic analysis, despite the fact that antibodies to glutamic acid decarboxylase may provide a link between the two conditions. The association between thyroid disorders and encephalopathies, often termed Hashimoto's encephalopathy, is well known but the pathogenic significance of antithyroid antibodies in this condition is still debated. In general, the relationships between autoimmune mechanisms and seizures in these conditions are unclear; the seizures are likely to be caused by a variety of mechanisms, including ischemia, neuronal damage, and specific and nonspecific immunity.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [31] Dendritic cells in autoimmune diseases and neuroinflammatory disorders
    Manuel, Sharron L.
    Rahman, Saifur
    Wigdahl, Brian
    Khan, Zafar K.
    Jain, Pooja
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4315 - 4335
  • [32] Pain in autoimmune disorders
    Mifflin, Katherine A.
    Kerr, Bradley J.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (06) : 1282 - 1294
  • [33] Immunosuppressive/Autoimmune Disorders
    Richard-Eaglin, Angela
    Smallheer, Benjamin A.
    NURSING CLINICS OF NORTH AMERICA, 2018, 53 (03) : 319 - +
  • [34] Autoimmune epilepsy
    Greco, Antonio
    Rizzo, Maria Ida
    De Virgilio, Armando
    Conte, Michela
    Gallo, Andrea
    Attanasio, Giuseppe
    Ruoppolo, Giovanni
    de Vincentiis, Marco
    AUTOIMMUNITY REVIEWS, 2016, 15 (03) : 221 - 225
  • [35] The Association Between Epilepsy and Autoimmune Diseases
    Issi, Elif Simin
    Ilhan Algin, Demet
    Erdinc, Oguz Osman
    EPILEPSI, 2021, 27 (01): : 32 - 38
  • [36] Emerging patterns of genetic overlap across autoimmune disorders
    Richard-Miceli, Corinne
    Criswell, Lindsey A.
    GENOME MEDICINE, 2012, 4
  • [37] Autoantibodies specific for α-enolase in systemic autoimmune disorders
    Pratesi, F
    Moscato, S
    Sabbatini, A
    Chimenti, D
    Bombardieri, S
    Migliorini, P
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (01) : 109 - 115
  • [38] Gut microbiota and autoimmune neurologic disorders: a two-sample bidirectional Mendelian randomization study
    Zhang, Mengyuan
    Fang, Jie
    Zheng, Chamou
    Lin, Qing
    Zhang, Jiawei
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [39] Migraine in Systemic Autoimmune Diseases
    Cavestro, Cinzia
    Ferrero, Marcella
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (02) : 124 - 134
  • [40] Type 1 Diabetes and Other Autoimmune Disorders in Children
    Grasso, Eleonora Agata
    Chiarelli, Francesco
    PEDIATRIC DIABETES, 2024, 2024